The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel

Andries Zijlstra1, James P Quigley

  • 1Department of Pathology, Vanderbilt University, Nashville, Tennessee 37232, USA.

Cancer Cell
|September 9, 2006
PubMed

Insights

Metastasis suppressors limit cancer spread. This study shows KAI1 on tumor cells interacting with DARC on vascular cells triggers tumor cell senescence, effectively suppressing metastasis.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metastasis Research

Background:

  • Tumor cell metastasis is a complex, inefficient process.
  • Metastasis suppressors and tumor-stroma interactions are key regulators of cancer progression.
  • The precise mechanisms by which metastasis suppressors function are still being elucidated.

Purpose of the Study:

  • To investigate the role of specific cell surface interactions in metastasis suppression.
  • To elucidate the mechanism by which the metastasis suppressor KAI1 influences tumor cell behavior.
  • To understand how stromal interactions restrain disseminating tumor cells.

Main Methods:

  • Investigated cell surface interactions between tumor cells and vascular cells.
  • Focused on the metastasis suppressor KAI1 and the decoy cytokine receptor DARC.
  • Analyzed the induction of senescence in tumor cells as a functional outcome.

Main Results:

  • Specific interaction between KAI1 on tumor cells and DARC on vascular cells was identified.
  • This interaction triggers senescence in tumor cells.
  • Tumor cell senescence mediated by this interaction effectively suppresses metastasis.

Conclusions:

  • Metastasis suppressors can relay stromal restraint signals to tumor cells.
  • The KAI1-DARC interaction is a novel mechanism for suppressing cancer metastasis.
  • Targeting this interaction may offer new therapeutic strategies for cancer treatment.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...